Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Thomas L, Holm"'
Autor:
Josué Castro-Mejía, Maja Jakesevic, Łukasz Krych, Dennis S. Nielsen, Lars H. Hansen, Bodil C. Sondergaard, Peter H. Kvist, Axel K. Hansen, Thomas L. Holm
Publikováno v:
Gastroenterology Research and Practice, Vol 2016 (2016)
Background and Aim. Crohn’s disease is associated with gut microbiota (GM) dysbiosis. Treatment with the anti-IL-12p40 monoclonal antibody (12p40-mAb) has therapeutic effect in Crohn’s disease patients. This study addresses whether a 12p40-mAb tr
Externí odkaz:
https://doaj.org/article/fb6f359e86ac4ef189daf717302497dc
Autor:
Christina Andersson, Peter H Kvist, Kathryn McElhinney, Richard Baylis, Luise K Gram, Hermann Pelzer, Brian Lauritzen, Thomas L Holm, Simon Hogan, David Wu, Brian Turpin, Whitney Miller, Joseph S Palumbo
Publikováno v:
PLoS ONE, Vol 10, Iss 6, p e0128113 (2015)
The thrombin-activated transglutaminase factor XIII (FXIII) that covalently crosslinks and stablizes provisional fibrin matrices is also thought to support endothelial and epithelial barrier function and to control inflammatory processes. Here, gene-
Externí odkaz:
https://doaj.org/article/f7fe539e40104b7b993051be90c862e4
Autor:
Zhiru Yang, Thomas Egebjerg, Karina Thorn, A. Henriksen, Stine Kjellev, Henrik Rahbek-Nielsen, Ida Hilden, Jais Rose Bjelke, Prafull S. Gandhi, Daniel Elenius, Søren Lund, Morten Grønbech Rasch, Jacob Lund, Carsten Dan Ley, Thomas L Holm, Mette Loftager, Mette B. Hermit, Per Jr Greisen, Rong Zhou, Marianne Kjalke, Bjarne Gram Hansen, Peter Thygesen, Nikolai Lorenzen, Henrik Østergaard, Kasper Lamberth
Publikováno v:
Blood. 134:96-96
The treatment of hemophilia A (HA) is primarily based on replacement of factor VIII (FVIII), and in people with HA with inhibitors (HAwI) on the use of by-passing agents. Recently, a FVIII mimetic bispecific antibody emicizumab (Hemlibra®) was appro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8233c553560d0f982127c10862cb5dc3
https://doi.org/10.1182/blood-2019-122817
https://doi.org/10.1182/blood-2019-122817
Autor:
Camilla H F, Hansen, Thomas L, Holm, Łukasz, Krych, Lars, Andresen, Dennis S, Nielsen, Ida, Rune, Axel K, Hansen, Søren, Skov
Publikováno v:
European journal of immunology. 43(2)
Intestinal epithelial cells (IECs) are one of a few cell types in the body with constitutive surface expression of natural killer group 2 member D (NKG2D) ligands, although the magnitude of ligand expression by IECs varies. Here, we investigated whet
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::0fa505d2a73c1a636bd9bf074c745e99
https://pubmed.ncbi.nlm.nih.gov/23136011
https://pubmed.ncbi.nlm.nih.gov/23136011